12月6日 Alison Gartland:Purinergic signalling pathways in bone loss and osteoarthritis(生命科学系列学术报告)


  Professor Alison Gartland studied for her PhD at The University of Liverpool, completed Post-Doctoral Researcher positions at IGMM, CNRS France and University of Massachusetts Medical School, USA. She is a Professor of Bone and Cancer Cell Biology at The University of Sheffield with expertise in purinergic signalling, bone and cancer cell biology, in vitro and in-vivo murine models of MSK disorders, including in the setting of both primary and secondary cancer. Her principal research area focus is on developing fundamental understanding of the basic cellular, molecular and genetic mechanisms responsible for musculoskeletal disease and cancer. Prof Gartland has over 50 publications in leading journals in the field of bone and cancer and has authored several book chapters on human bone cell culture techniques and osteosarcoma. She is the President of the UK Purine Club, past Secretary of the Bone Research Society, past Topic Chair of the Orthopaedic Research Society Annual Meeting Committee, and member of the International Scientific Programme Committee member for the International Purines meetings since 2014. Prof Gartland also serves on the Editorial board of Frontiers in Endocrinology (Bone Research), Purinergic Signalling and Journal of Medicines Development Sciences. She was previously a Current Opinion in Pharmacology Section Editor and editor for Scientific Reports. She currently sits on the Med4 Cancer panel for the Research Foundation - Flanders (FWO), The Children's Hospital Charity Scientific Advisory Committee and previously on the Arthritis Research UK Scientific Advisory committee. She is a regular external and internal examiner for individual higher and undergraduate degrees, as well as an external examiner for master level courses. She has been invited speaker and chairperson at numerous prestigious international conferences. Her scientific research and outreach activities regularly attract Media coverage including international press coverage, BBC World TV, BBC radio stations and various international online health and science websites.